Hisham Farouk
Overview
Explore the profile of Hisham Farouk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Price D, Beekman M, Mattarucco W, Barriga-Acevedo R, Wang H, Diaz D, et al.
NPJ Prim Care Respir Med
. 2024 Nov;
34(1):34.
PMID: 39487159
This post-hoc analysis of the SABINA III study evaluated the association of short-acting β-agonist (SABA) prescriptions and self-reported over-the-counter (OTC) SABA purchase in the previous 12 months with asthma-related outcomes...
2.
Athanazio R, Bernal Villada L, Avdeev S, Wang H, Ramirez-Venegas A, Sivori M, et al.
BMJ Open Respir Res
. 2024 Apr;
11(1).
PMID: 38637115
Introduction: The cerbations of hronic obstructive lung disease (COPD) and their utcome (EXACOS) International Study aimed to quantify the rate of severe exacerbations and examine healthcare resource utilisation (HCRU) and...
3.
Alzaabi A, Bell J, Montero-Arias F, Price D, Jackson D, Wang H, et al.
Adv Ther
. 2023 Sep;
40(11):4836-4856.
PMID: 37684493
Introduction: Healthcare systems are looking to reduce their carbon impact. Short-acting β-agonist (SABA) overuse (≥ 3 canisters/year) is common in asthma and linked to poor outcomes; however, its environmental impact...
4.
Maspero J, Cruz A, Pozo Beltran C, Munive A, Montero-Arias F, Hernandez Pliego R, et al.
World Allergy Organ J
. 2023 May;
16(4):100760.
PMID: 37179538
The stepwise treatment approach recommended by the Global Initiative for Asthma (GINA) includes systemic corticosteroids (SCS) suggested as a final step if asthma is severe and/or difficult to treat. Yet,...
5.
Price D, Hancock K, Doan J, Taher S, Muhwa C, Farouk H, et al.
NPJ Prim Care Respir Med
. 2022 Sep;
32(1):37.
PMID: 36175556
Short-acting β-agonist (SABA) prescriptions and associated outcomes were assessed in 1440 patients with asthma from the SABA use IN Asthma (SABINA) III study treated in primary care. Data on asthma...
6.
Alzaabi A, Al Busaidi N, Pradhan R, Shandy F, Ibrahim N, Ashtar M, et al.
Asthma Res Pract
. 2022 Jul;
8(1):3.
PMID: 35799290
Background: The overuse of short-acting β-agonists (SABA) is associated with poor asthma control. However, data on SABA use in the Gulf region are limited. Herein, we describe SABA prescription practices...
7.
Al-Ahmad M, Mobayed H, Al Busaidi N, Iqbal M, Al Mubaihsi S, Khadadah M, et al.
World Allergy Organ J
. 2022 Jun;
15(5):100647.
PMID: 35663273
Background: While crucial to the assessment and improvement of asthma control, insights on treatment practices in patients with severe diseases across Gulf nations are lacking. This observational study describes the...
8.
Ibrahim N, Almarzouqi F, Al Melaih F, Farouk H, Alsayed M, AlJassim F
World Allergy Organ J
. 2021 Oct;
14(10):100588.
PMID: 34703522
Background: Asthma, allergic rhinitis, and atopic dermatitis are the most common chronic inflammatory disorders in children worldwide. These conditions place a significant burden on the healthcare system due to their...
9.
Bassam M, Behbehani N, Farouk H, Alsayed M, Montestruc F, Al-Jahdali H, et al.
Respir Med
. 2020 Nov;
176:106244.
PMID: 33253971
Background: Low levels of adherence to asthma medication is reported in many countries worldwide. Improved knowledge of adherence in the Middle East and North Africa (MENA) is needed to address...